Genesys International Announces Rights Issue of ₹1253.71 Crore
Genesys International is launching a rights issue to raise ₹1253.71 crore by issuing 2.5 crore shares at ₹50 each. The issue ratio is 3:5, with a record date of August 6, 2026. The issue opens on August 14, 2026, and closes on August 21, 2026.
A rights issue of this size can impact the company's capital structure and potentially dilute existing shareholders' stakes. It is a significant corporate action that requires careful consideration by investors, hence a medium impact.
The announcement is a standard disclosure regarding a rights issue, providing details of the offering, timeline, and company background. It does not contain information that inherently suggests a positive or negative outlook beyond the company's capital-raising activity.
Genesys International Corporation Limited is undertaking a rights issue to raise ₹12,537.11 lakhs (₹1253.71 crore) by issuing 2,50,74,226 fully paid-up equity shares of face value ₹5 each at a price of ₹50 per share, including a premium of ₹45 per share. This issue is structured on a rights basis, offering 3 rights equity shares for every 5 fully paid-up equity shares held by eligible shareholders as of the record date, August 06, 2026. The payment schedule requires ₹5 towards face value and ₹45 towards premium on application for each rights equity share. The issue opens on Friday, August 14, 2026, the last date for on-market renunciation is Tuesday, August 18, 2026, and the issue closes on Friday, August 21, 2026. The company has received in-principle approvals from BSE and NSE for listing the rights equity shares, with BSE designated as the stock exchange for this issue.
The company history traces back to its incorporation as Aeke Trading & Investments Limited in 1983, with a significant amalgamation and name change to Genesys International Corporation Limited in 2000. The promoters of the company include Sajid Siraj Malik, Sohel Malik, Kilam Holdings Limited, and Kadam Holding Limited. The Letter of Offer serves as a detailed document for eligible equity shareholders, outlining the terms, risks, and procedures associated with the rights issue. The company confirms that neither it nor its promoters or directors have been identified as willful defaulters or fraudulent borrowers by any authority.
What to do with a filing like this
Genesys International Corporation Limited filed this with the NSE as a statutory disclosure, categorised under rights issue. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Genesys International Corporation Limited. Read the original for the full detail.